0001181431-15-005711.txt : 20150409
0001181431-15-005711.hdr.sgml : 20150409
20150409172046
ACCESSION NUMBER: 0001181431-15-005711
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150407
FILED AS OF DATE: 20150409
DATE AS OF CHANGE: 20150409
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CYNOSURE INC
CENTRAL INDEX KEY: 0000885306
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 043125110
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
BUSINESS PHONE: (978) 256-4200
MAIL ADDRESS:
STREET 1: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davin Michael R
CENTRAL INDEX KEY: 0001345975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51623
FILM NUMBER: 15762138
MAIL ADDRESS:
STREET 1: C/O CYNOSURE, INC.
STREET 2: 5 CARLISLE ROAD
CITY: WESTFORD
STATE: MA
ZIP: 01886
4
1
rrd424240.xml
MD EXERCISE
X0306
4
2015-04-07
0
0000885306
CYNOSURE INC
CYNO
0001345975
Davin Michael R
C/O CYNOSURE, INC.
5 CARLISLE ROAD
WESTFORD
MA
01886
1
1
0
0
Chairman and CEO
Class A Common Stock
2015-04-07
4
M
0
61941
16.46
A
61941
D
Class A Common Stock
2015-04-07
4
S
0
61941
32.0016
D
0
D
Class A Common Stock
2015-04-08
4
M
0
6009
16.46
A
6009
D
Class A Common Stock
2015-04-08
4
S
0
6009
32.0208
D
0
D
Class A Common Stock
2015-04-09
4
M
0
2050
16.46
A
2050
D
Class A Common Stock
2015-04-09
4
S
0
2050
32.00
D
0
D
Employee Stock Option (right to buy)
16.46
2015-04-07
4
M
0
61941
0
D
2022-02-15
Class A Common Stock
61941
8059
D
Employee Stock Option (right to buy)
16.46
2015-04-08
4
M
0
6009
0
D
2022-02-15
Class A Common Stock
6009
2050
D
Employee Stock Option (right to buy)
16.46
2015-04-09
4
M
0
2050
0
D
2022-02-15
Class A Common Stock
2050
0
D
The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $32.00 to $32.15 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The option became exercisable as to approximately 8.33% of the shares on each three-month anniversary of the 2/15/2012 grant date.
The sales price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $32.00 to $32.09 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Timothy W. Baker, Attorney-in-Fact
2015-04-09